About
About Sutro
Partnerships
Leadership
Leadership Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Technology
XpressCF® and XpressCF+™ Platforms
Antibody-Drug Conjugates and IADCs
Bispecific and Engineered Antibodies
cGMP Facility
Investors
Company Presentation
Stock
Financials
Governance
Contact IR
Email Alerts
Pipeline
News
News Releases
Clinical / Scientific Presentation and Publication Highlights
Events
Careers
Join Our Team
Internships
Sutroites
Contact Us
Changing the future of
Oncology.
Sutro’s CEO, Bill Newell was Live Today on TD Ameritrade, The Watch List
Nov 20, 2019
